VitaNova Life Sciences Corp (VNOV) stock
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
VitaNova Life Sciences's revenue for the twelve months ending Jul 31, 2026 was $3.24M, up 22.0% year over year. For fiscal 2026 it was $3.03M, up 13.7% from the year before. The highest annual figure on record is $3.03M in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $3.03M | +13.7% |
| FY2025 | Apr 30, 2025 | $2.66M | +366.5% |
| FY2024 | Apr 30, 2024 | $570.69K | +1401.8% |
| FY2023 | Apr 30, 2023 | $38.00K | -68.3% |
| FY2022 | Apr 30, 2022 | $120.00K | – |
| FY2021 | Apr 30, 2021 | $0 | – |
| FY2020 | Apr 30, 2020 | $0 | – |
| FY2019 | Apr 30, 2019 | $0 | – |
| FY2017 | Jan 25, 2017 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $321.58K | +209.5% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | $1.78M | -8.6% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | $709.63K | +130.2% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | $427.12K | +46.2% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | $103.90K | -4.2% |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | $1.95M | +258.7% |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | $308.32K | +1081.3% |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | $292.12K | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | $108.48K | – |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | $544.59K | +18053.1% |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | $26.10K | +161.0% |
| Q2 FY2024CQ3 2023 | Oct 31, 2023 | $0 | -100.0% |
| Q1 FY2024CQ2 2023 | Jul 31, 2023 | $0 | -100.0% |
| Q4 FY2023CQ1 2023 | Apr 30, 2023 | $3.00K | -93.3% |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | $10.00K | -66.7% |
| Q2 FY2023CQ3 2022 | Oct 31, 2022 | $10.00K | -77.8% |
| Q1 FY2023CQ2 2022 | Jul 31, 2022 | $15.00K | – |
| Q4 FY2022CQ1 2022 | Apr 30, 2022 | $45.00K | – |
| Q3 FY2022CQ4 2021 | Jan 31, 2022 | $30.00K | – |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | $45.00K | – |
| Q1 FY2022CQ2 2021 | Jul 31, 2021 | $0 | – |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $0 | – |
| Q3 FY2021CQ4 2020 | Jan 31, 2021 | $0 | – |
| Q2 FY2021CQ3 2020 | Oct 31, 2020 | $0 | – |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $0 | – |
| Q4 FY2020CQ1 2020 | Apr 30, 2020 | $0 | – |
| Q3 FY2020CQ4 2019 | Jan 31, 2020 | $0 | – |
| Q2 FY2020CQ3 2019 | Oct 31, 2019 | $0 | – |
| Q1 FY2020CQ2 2019 | Jul 31, 2019 | $0 | – |
| Q4 FY2019CQ1 2019 | Apr 30, 2019 | $0 | – |
| Q1 FY2019CQ2 2018 | Jul 31, 2018 | $0 | – |
See a number that looks wrong?